Fischer Medical Ventures logo

Fischer Medical Ventures financials and balance sheet

NSE: FISCHERBSE: 524743Healthcare Equipment & SuppliesSmall Cap

Last close ₹24.88up ₹1.01 (4.23%)BSE ₹24.95

Share price at the NSE close on 23 Oct 2026. Previous close ₹23.87.

52-week range of traded prices to 23 Oct 2026
₹21.78Low, 23 Oct 2026₹121.70High, 29 Oct 2025
Market cap
₹1,738 Cr1,073rd largest listed
P/E
58.1
P/B
Shares changed
Dividend yield
0.20%
ROE
8.3%
ROCE
10.2%
Debt to equity
0.19
Volume, NSE
91,74,21521.6% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Fischer Medical Ventures annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹17 Cr, year to Mar 2026A loss in the year to Mar 2026, −₹10 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue17
  2. Materials and goods−12
  3. Employee costs−2.0
  4. Other expenses−12
  5. Operating profit−8.7
  6. Depreciation−0.7
  7. Other income+3.5
  8. One-off items0.0
  9. Finance costs−4.7
  10. Profit before tax−11
  11. Tax+0.1
  12. Net profit−10

What the company owns

  • Plant, investments and other assets₹366 Cr
  • Receivables₹21 Cr
  • Cash and bank₹1 Cr
  • Inventory₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹338 Cr
  • Other liabilities₹34 Cr
  • Borrowings₹13 Cr
  • Owed to suppliers₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March.Fischer Medical Ventures quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 6 JunMar 2020Filed 27 JunMar 2021Filed 29 JunMar 2022Filed 14 JunMar 2023Filed 30 MayMar 2024Filed 19 JulMar 2025Filed 13 JunMar 2026Filed 31 May
Revenue from operations0.10.20.20.20.20.00.211.55.217.4
––0.20.20.20.20.111.77.526.1
Materials and goods bought––0.00.00.00.00.010.74.511.6
Employee costs––0.00.10.10.10.00.10.12.0
Other expenses––0.20.10.10.10.10.92.812.4
Operating profit before depreciation––0.00.00.0−0.20.0−0.2−2.2−8.7
Operating margin––2.9%−12.5%−10.7%–25.8%−1.7%−42.9%−49.8%
Materials, % of revenue––0.0%0.0%0.0%–0.0%93.0%87.1%66.7%
Employee costs, % of revenue––10.5%48.4%48.2%–9.2%0.5%2.5%11.6%
Other expenses, % of revenue––86.5%64.1%62.4%–65.0%8.2%53.3%71.5%
Depreciation and amortisation––0.00.00.00.00.00.00.10.7
Operating profit after depreciation––0.00.00.0−0.20.0−0.2−2.4−9.3
Other income0.10.20.00.00.00.00.00.83.53.5
Finance costs––0.00.00.00.00.00.00.14.7
One-off items––0.00.00.00.00.00.00.00.0
Profit before tax−0.10.00.00.00.0−0.20.00.51.0−10.5
––0.00.0−0.20.00.00.10.3−0.1
Net profit−0.10.00.00.00.1−0.20.00.40.7−10.4
Net margin−94.3%−0.5%2.3%−22.3%85.2%–−20.3%3.5%12.7%−59.9%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2017 and Mar 2018: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Earlier years, Mar 2009 to Mar 2016
₹ croreMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations2.611.442.091.640.690.040.110.09
2.491.531.89–2.66–––
Materials and goods bought1.390.460.720.771.06–0.02–
Employee costs0.340.420.32–0.49–––
Other expenses0.790.680.87–1.13–––
Operating profit before depreciation0.11−0.090.20–−1.97–––
Operating margin4.4%−5.9%9.6%–−286.4%–––
Materials, % of revenue53.5%31.6%34.2%–153.4%–––
Employee costs, % of revenue13.0%29.2%15.5%–71.0%–––
Other expenses, % of revenue30.2%47.0%41.4%–163.7%–––
Depreciation and amortisation0.320.300.30–0.19–––
Operating profit after depreciation−0.20−0.38−0.10–−2.16–––
Other income0.92––––0.07––
Finance costs0.030.030.010.010.01–––
Profit before one-off items and tax0.66−0.44−0.12−0.60−2.190.010.03−0.03
One-off items––––3.25–––
Profit before tax0.66−0.44−0.12−0.601.060.010.03−0.03
Tax0.03––−0.02−0.26–––
Net profit0.58−0.44−0.12−0.581.320.010.03−0.03
Net margin22.4%−30.3%−5.7%−35.2%191.3%11.4%24.5%−36.7%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 6 JunMar 2020Filed 27 JunMar 2021Filed 29 JunMar 2022Filed 14 JunMar 2023Filed 30 MayMar 2024Filed 19 JulMar 2025Filed 13 JunMar 2026Filed 31 May
0000080336338
Share capital00000546465
Reserves0000026272273
000010013
0000112712
0000001639
Total assets0000092359389
0000041331359
00000512830
Net debt000010012
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 29 JunMar 2022Filed 14 JunMar 2023Filed 30 MayMar 2024Filed 19 JulMar 2025Filed 13 JunMar 2026Filed 31 May
0000−23−3
0000−24−3
0000−25−1
Receivables000−13−4−4
Inventories000000
Payables00012−123
Other working capital0000−91
Tax paid000000
Interest paid000000
Capital spending000000
Free cash flow0000−23−3
000−38−232−13
000−125517
Dividends paid000000
Shares bought back000000
Shares issued00004013
Net change in cash000−3801
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Fischer Medical Ventures dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 6 JunMar 2020Filed 27 JunMar 2021Filed 29 JunMar 2022Filed 14 JunMar 2023Filed 30 MayMar 2024Filed 19 JulMar 2025Filed 13 JunMar 2026Filed 31 May
–₹0.00₹0.03−₹0.24₹0.82−₹1.35−₹0.21–₹0.01−₹0.16
As stated that year−₹0.19−₹0.01₹0.26−₹2.39₹8.18−₹13.52−₹2.12–₹0.05−₹0.16
–₹0.00–−₹0.24₹0.82−₹1.35−₹0.21–₹0.00−₹0.15
Dividend per share––––––––₹0.01₹0.05
––−₹0.56−₹0.80₹0.02−₹1.33−₹1.55₹1.49₹5.26₹5.17
Dividend payout––––––––48.1%–
Shareholder yield––––0.0%0.0%0.0%0.0%−0.8%−0.5%
Market cap at the year end (₹ crore)10110111564,8032,626
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from. As stated that year and earnings per share are left blank for the year to Mar 2024: the earnings per share stated has the opposite sign to the profit stated beside it, so it is not shown.
RatioMar 2017Mar 2018Mar 2019Filed 6 JunMar 2020Filed 27 JunMar 2021Filed 29 JunMar 2022Filed 14 JunMar 2023Filed 30 MayMar 2024Filed 19 JulMar 2025Filed 13 JunMar 2026Filed 31 May
Revenue growth−22.2%180.0%−1.8%−4.5%−10.3%−100.0%–6,322.5%−54.7%233.2%
Net profit growth––––––––64.6%–
––−4.7%35.0%−209.2%–14.7%1.0%0.3%−3.1%
–––39.7 pts−244.3 pts––−13.7 pts−0.7 pts−3.4 pts
From the net margin–––49.2 pts−169.0 pts––−17.2 pts2.7 pts−1.8 pts
From asset turnover–––−6.4 pts57.8 pts––1.6 pts−3.3 pts−1.5 pts
From borrowing–––−3.0 pts−133.0 pts––2.0 pts0.0 pts−0.1 pts
Return on capital employed––5.4%−29.2%−7.5%−118.2%15.1%−0.2%−0.7%−2.7%
Cash conversion––––−40.8%––19.8%−3,438.8%–
Interest cover––––––1.0–––
Debt to equity––––75.10––0.000.000.04
Receivable days––000–3474021,194435
Inventory days–––––––0513
Payable days–––––––41032115
Cash conversion cycle, days–––––––−81,168333
Working capital days––23−4933–3341,2151,408348
Asset turnover––1.741.490.850.000.660.250.020.05
Assets per rupee of net worth––−1.15−1.06−2.90−1.96−1.101.161.081.11
Sales per rupee of plant–––––––1,987.641,373.61597.66
Capital spending to depreciation–––––––8.250.000.04
Debt to equity is left blank for the years to Mar 2019, Mar 2020, Mar 2022 and Mar 2023: net worth is below zero, so there is no shareholders' money to set the borrowings against. Interest cover is left blank for the years to Mar 2020, Mar 2021, Mar 2022, Mar 2024, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−2.8%
Measure10 years5 years3 years
Revenue growth, yearly rate69.3%153.8%359.3%
Return on equity, average–3.2%−0.6%
Return on capital employed, average–−21.3%−1.2%
Operating margin, average–−17.2%−31.5%
Net margin, average−10.4%−16.0%−14.6%
Asset turnover, average–0.200.11
Cash conversion cycle, days, average––498
Debt to equity, average––0.01

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−26−26−3
Cash from investing−283−283−13
Cash from financing27227117
Capital spending000
Dividends paid000
Shares bought back000
Shares issued for cash535313
Borrowings raised––13
Borrowings repaid000

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––5––52–
Altman Z-scorePublished threshold 1.812.550.180.82−6.64−0.66–––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––101.46−25.1040.2782.68––
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––−1.82−22.22–
Receivables growth less revenue growthOur threshold 0 percentage points–––––1,022.45––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–7.46−0.27–4.350.17––
Effective tax ratePublished threshold 17.16 per cent19.64–––––––
A threshold marked as ours has no published figure; it is the line we read the check against.